Covid-19 Pharma Insights
Moderna v Pfizer-BioNTech: Lessons to be learnt from post-pandemic disputes
Dr. Nicholas Jones, partner and patent attorney at Withers & Rogers, discusses what the pharma industry can learn from its experiences of working collaboratively during the COVID-19 pandemic by establishing best practice and minimising risks. Read more
13 Sep 2022
Using genomic sequencing to predict COVID’s next move
Brittany Niccum, Beckman Coulter Life Sciences, shares how genomic sequencing and laboratory automation can monitor new variants of COVID and potentially nip them in the bud, before they transform into future pandemics. Read more
17 Aug 2022
Wastewater is anything but a waste: It could even prevent the next pandemic
Ari Goldfarb, CEO, Kando, discusses how innovative technologies and artificial intelligence tools are advancing wastewater analysis and could potentially mitigate the effects, or even prevent, future pandemics. Read more
26 Jul 2022
Opinion: Pandemic preparedness
Martin Stocks, CEO of Iceni Glycoscience, discusses how preparedness for the pandemic relies on leveraging the technologies and insights of innovative startups. Read more
25 May 2022
The MedTalk Podcast - How iiCON is driving innovation in the UK and beyond
We speak to professor Janet Hemingway, the founding director of the Infection Innovation Consortium (iiCON) to find out all about the work the organisation has done throughout the Covid-19 pandemic. Read more
1 Feb 2022
The future of Covid-19 vaccinations
Ivor Campbell managing director of Snedden Campbell discusses the future of Covid-19 vaccination and why testing is crucial amidst falling antibody levels. Read more
30 Nov 2021
PrecisionLife and Metrodora Institute Partner
PrecisionLife and Metrodora Institute are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren's syndrome, and many more. Read more
26 Feb 2024
Osivax Announce First-in-Human Phase 1 Vaccination Trial
Osivax have announced that the first participant has been vaccinated in its new Phase 1 trial (NCT06128382) evaluating OVX033, a broad-spectrum sarbecovirus vaccine candidate. Read more
15 Feb 2024
Virios Therapeutics to Develop Long Covid Therapy
Virios Therapeutics, Inc have announced plans for advancing IMC-2 (combination of valacyclovir and celecoxib) as a treatment for the fatigue, orthostatic intolerance and other symptoms associated with long covid. Read more
24 Jan 2024
Signposting the route to sustainable devices with life-cycle assessment
Alex Fong, insights and sustainability lead, Owen Mumford, addresses the environmental impact of single-use drug delivery devices and emphasises the role of life-cycle assessment (LCA) in sustainable design. Read more
18 Nov 2024
Futureproofing medicines manufacturing with virtual solutions
Editor Rebekah Jordan speaks to Ivan Wall, a professor at the University of Birmingham and co-director of the Resilience project, to learn about the advancements the initiative is making in UK medicines manufacturing. Read more
15 Nov 2024
Three essential tips for stability partner selection
Broughton highlights the top three tips in choosing a stability partner and explains how its extensive expertise positions it as a leader in stability testing. Read more
12 Nov 2024
Trends shaping collaborations in drug development and manufacturing
Given the success of nasal drug-delivery products relies on balancing formulation and device selection, Eric Kaneps at Renaissance Lakewood, LLC explains the importance of partnerships and collaborations drug development and manufacturing. Read more
8 Nov 2024
Biometric ID drives security and efficiency in pharma manufacturing
Paul Shu of ARISTA Corporation, explains how pharma manufacturers are increasingly turning to wearable biometric ID products to securely speed authentication in a hands-free manner. Read more
18 Oct 2024
How can you use content to achieve goals beyond the usual scope?
Nataliya Andreychuk, CEO and co-founder of Viseven, explores how to leverage content in pharma beyond traditional marketing goals, highlighting customer education, societal influence, product development and policy impact. Read more
15 Oct 2024
Sponsored Content
Why Pharmaceutical Industry Needs a Digital Content Factory (DCF)?
Modern pharma brands pursue a higher degree of content personalisation to engage with diverse audiences. This means tighter deadlines, higher workloads, and a greater demand for skilled content creators than ever before. Read more